Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients
- 1 January 2002
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 193 (2) , 73-78
- https://doi.org/10.1016/s0022-510x(01)00661-x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Dose-ranging study of riluzole in amyotrophic lateral sclerosisThe Lancet, 1996
- Amyotrophic lateral sclerosis is a multifactorial diseaseMuscle & Nerve, 1995
- A Controlled Trial of Riluzole in Amyotrophic Lateral SclerosisNew England Journal of Medicine, 1994
- Excitatory amino acids in amyotrophic lateral sclerosis: An updateAnnals of Neurology, 1991
- Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosisAnnals of Neurology, 1990
- Amyotrophic lateral sclerosis: Amino acid levels in plasma and cerebrospinal fluidAnnals of Neurology, 1990
- Free amino acid pattern of cerebrospinal fluid in amyotrophic lateral sclerosisActa Neurologica Scandinavica, 1988
- Abnormal glutamate metabolism in amyotrophic lateral sclerosisAnnals of Neurology, 1987
- Elevated levels of amino acids in the CSF of motor neuron disease patientsNeurochemical Pathology, 1984
- Free amino acid levels in amyotrophic lateral sclerosisAnnals of Neurology, 1978